Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia

Pu Xia, Toyoshi Inoguchi, Timothy S. Kern, Ronald L. Engerman, Peter J. Oates, George L. King

    Research output: Contribution to journalArticle

    376 Citations (Scopus)

    Abstract

    Similar vascular pathological conditions are observed in diabetic animals and those with diet-induced hypergalactosemia. Both diabetes and hypergalactosemia are believed to cause vascular dysfunction via a common biochemical mechanism. In this study, we have found that both diabetes and hypergalactosemia in the short term (2-4 months) can increase total diacylglycerol (DAG) levels by 52 ± 9 and 74 ± 13% in the retina and aorta, respectively, of diabetic dogs, and by 94 ± 9 and 78 ± 11% in the retina and aorta, respectively, in dogs with hypergalactosemia as compared with normal control animals (P < 0.01). The elevation of DAG levels was maintained for 5 years in the aortas of diabetic and hypergalactosemic dogs. To characterize the mechanism of the DAG increases, we have determined that total DAG levels were significantly increased in cultured macro- and microvascular cells exposed to elevated glucose (22 mM) and galactose (16.5 mM) levels. These increased levels were not prevented by sorbinil, an aldose reductase inhibitor. One of the sources of the increased DAG levels was probably derived from de novo synthesis from both hexoses as determined by radiolabeling studies. Intracellularly, the DAG elevation activated protein kinase C (PKC) activity with increases of 58 ± 12% (P < 0.05) and 66 ± 8% (P < 0.01) in the membrane fraction of cultured aortic smooth muscle cells exposed to elevated glucose and galactose levels, respectively. These findings have clearly demonstrated a possible common biochemical mechanism by which hyperglycemia and hypergalactosemia can chronically activate the DAG- PKC pathway in the vasculature and could be a possible explanation for the development of diabetic vascular complications.

    Original languageEnglish
    Pages (from-to)1122-1129
    Number of pages8
    JournalDiabetes
    Volume43
    Issue number9
    DOIs
    Publication statusPublished - Jan 1 1994

    Fingerprint

    Diacylglycerol Kinase
    Diglycerides
    Protein Kinase C
    Aorta
    Dogs
    Galactose
    Blood Vessels
    Retina
    Glucose
    Diabetic Angiopathies
    Aldehyde Reductase
    Hexoses
    Hyperglycemia
    Smooth Muscle Myocytes
    Diet
    Membranes

    All Science Journal Classification (ASJC) codes

    • Internal Medicine
    • Endocrinology, Diabetes and Metabolism

    Cite this

    Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. / Xia, Pu; Inoguchi, Toyoshi; Kern, Timothy S.; Engerman, Ronald L.; Oates, Peter J.; King, George L.

    In: Diabetes, Vol. 43, No. 9, 01.01.1994, p. 1122-1129.

    Research output: Contribution to journalArticle

    Xia, Pu ; Inoguchi, Toyoshi ; Kern, Timothy S. ; Engerman, Ronald L. ; Oates, Peter J. ; King, George L. / Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. In: Diabetes. 1994 ; Vol. 43, No. 9. pp. 1122-1129.
    @article{b2bb90dbda5d4e7aa7d9402726905ef5,
    title = "Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia",
    abstract = "Similar vascular pathological conditions are observed in diabetic animals and those with diet-induced hypergalactosemia. Both diabetes and hypergalactosemia are believed to cause vascular dysfunction via a common biochemical mechanism. In this study, we have found that both diabetes and hypergalactosemia in the short term (2-4 months) can increase total diacylglycerol (DAG) levels by 52 ± 9 and 74 ± 13{\%} in the retina and aorta, respectively, of diabetic dogs, and by 94 ± 9 and 78 ± 11{\%} in the retina and aorta, respectively, in dogs with hypergalactosemia as compared with normal control animals (P < 0.01). The elevation of DAG levels was maintained for 5 years in the aortas of diabetic and hypergalactosemic dogs. To characterize the mechanism of the DAG increases, we have determined that total DAG levels were significantly increased in cultured macro- and microvascular cells exposed to elevated glucose (22 mM) and galactose (16.5 mM) levels. These increased levels were not prevented by sorbinil, an aldose reductase inhibitor. One of the sources of the increased DAG levels was probably derived from de novo synthesis from both hexoses as determined by radiolabeling studies. Intracellularly, the DAG elevation activated protein kinase C (PKC) activity with increases of 58 ± 12{\%} (P < 0.05) and 66 ± 8{\%} (P < 0.01) in the membrane fraction of cultured aortic smooth muscle cells exposed to elevated glucose and galactose levels, respectively. These findings have clearly demonstrated a possible common biochemical mechanism by which hyperglycemia and hypergalactosemia can chronically activate the DAG- PKC pathway in the vasculature and could be a possible explanation for the development of diabetic vascular complications.",
    author = "Pu Xia and Toyoshi Inoguchi and Kern, {Timothy S.} and Engerman, {Ronald L.} and Oates, {Peter J.} and King, {George L.}",
    year = "1994",
    month = "1",
    day = "1",
    doi = "10.2337/diab.43.9.1122",
    language = "English",
    volume = "43",
    pages = "1122--1129",
    journal = "Diabetes",
    issn = "0012-1797",
    publisher = "医学出版",
    number = "9",

    }

    TY - JOUR

    T1 - Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia

    AU - Xia, Pu

    AU - Inoguchi, Toyoshi

    AU - Kern, Timothy S.

    AU - Engerman, Ronald L.

    AU - Oates, Peter J.

    AU - King, George L.

    PY - 1994/1/1

    Y1 - 1994/1/1

    N2 - Similar vascular pathological conditions are observed in diabetic animals and those with diet-induced hypergalactosemia. Both diabetes and hypergalactosemia are believed to cause vascular dysfunction via a common biochemical mechanism. In this study, we have found that both diabetes and hypergalactosemia in the short term (2-4 months) can increase total diacylglycerol (DAG) levels by 52 ± 9 and 74 ± 13% in the retina and aorta, respectively, of diabetic dogs, and by 94 ± 9 and 78 ± 11% in the retina and aorta, respectively, in dogs with hypergalactosemia as compared with normal control animals (P < 0.01). The elevation of DAG levels was maintained for 5 years in the aortas of diabetic and hypergalactosemic dogs. To characterize the mechanism of the DAG increases, we have determined that total DAG levels were significantly increased in cultured macro- and microvascular cells exposed to elevated glucose (22 mM) and galactose (16.5 mM) levels. These increased levels were not prevented by sorbinil, an aldose reductase inhibitor. One of the sources of the increased DAG levels was probably derived from de novo synthesis from both hexoses as determined by radiolabeling studies. Intracellularly, the DAG elevation activated protein kinase C (PKC) activity with increases of 58 ± 12% (P < 0.05) and 66 ± 8% (P < 0.01) in the membrane fraction of cultured aortic smooth muscle cells exposed to elevated glucose and galactose levels, respectively. These findings have clearly demonstrated a possible common biochemical mechanism by which hyperglycemia and hypergalactosemia can chronically activate the DAG- PKC pathway in the vasculature and could be a possible explanation for the development of diabetic vascular complications.

    AB - Similar vascular pathological conditions are observed in diabetic animals and those with diet-induced hypergalactosemia. Both diabetes and hypergalactosemia are believed to cause vascular dysfunction via a common biochemical mechanism. In this study, we have found that both diabetes and hypergalactosemia in the short term (2-4 months) can increase total diacylglycerol (DAG) levels by 52 ± 9 and 74 ± 13% in the retina and aorta, respectively, of diabetic dogs, and by 94 ± 9 and 78 ± 11% in the retina and aorta, respectively, in dogs with hypergalactosemia as compared with normal control animals (P < 0.01). The elevation of DAG levels was maintained for 5 years in the aortas of diabetic and hypergalactosemic dogs. To characterize the mechanism of the DAG increases, we have determined that total DAG levels were significantly increased in cultured macro- and microvascular cells exposed to elevated glucose (22 mM) and galactose (16.5 mM) levels. These increased levels were not prevented by sorbinil, an aldose reductase inhibitor. One of the sources of the increased DAG levels was probably derived from de novo synthesis from both hexoses as determined by radiolabeling studies. Intracellularly, the DAG elevation activated protein kinase C (PKC) activity with increases of 58 ± 12% (P < 0.05) and 66 ± 8% (P < 0.01) in the membrane fraction of cultured aortic smooth muscle cells exposed to elevated glucose and galactose levels, respectively. These findings have clearly demonstrated a possible common biochemical mechanism by which hyperglycemia and hypergalactosemia can chronically activate the DAG- PKC pathway in the vasculature and could be a possible explanation for the development of diabetic vascular complications.

    UR - http://www.scopus.com/inward/record.url?scp=0027981889&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0027981889&partnerID=8YFLogxK

    U2 - 10.2337/diab.43.9.1122

    DO - 10.2337/diab.43.9.1122

    M3 - Article

    VL - 43

    SP - 1122

    EP - 1129

    JO - Diabetes

    JF - Diabetes

    SN - 0012-1797

    IS - 9

    ER -